NCT06082323 - A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers | Biotech Hunter

Enrollment

127

Participants

Timeline

Start Date

June 13, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

June 1, 2025

Conditions

Healthy VolunteerHidradenitis SuppurativaAtopic Dermatitis

Interventions

DRUG

LT-002-158/Placebo oral tablet(s)

Single ascending dose escalation and multiple ascending dose escalation study followed by an evaluation of food effects on absorption Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Trial Locations (1)

200031

RECRUITING

Shanghai Xuhui Distric Central Hospital, Shanghai